Deferasirox prevents progression of non-alcoholic steatohepatitis in a mouse model with inhibition of heaptic fibrosis and hepatocellular ballooning

被引：0
|
作者：
Korenaga, Masaaki [1 ]
Korenaga, Keiko [1 ]
Mizokami, Masashi [1 ]
Kanto, Tatsuya [1 ]
机构：
[1] Natl Ctr Global Hlth & Med NCGM Kohnodai, Res Ctr Hepstitis & Immunol, Ichikawa, Japan
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1583
引用
收藏
页码：785A / 786A
页数：2
相关论文
共 50 条
  • [11] Synthesized HMGB1 peptide prevents the progression of inflammation, steatosis, fibrosis, and tumor occurrence in a non-alcoholic steatohepatitis mouse model
    Ishii, Yui
    Tsuchiya, Atsunori
    Natsui, Kazuki
    Koseki, Youhei
    Takeda, Nobutaka
    Tomiyoshi, Kei
    Yamazaki, Fusako
    Yoshida, Yuki
    Shimbo, Takashi
    Tamai, Katsuto
    Terai, Shuji
    HEPATOLOGY RESEARCH, 2022, 52 (12) : 985 - 997
  • [12] Clinical and pathological progression of non-alcoholic steatohepatitis to hepatocellular carcinoma
    Yasui, Kohichiroh
    Hashimoto, Etsuko
    Tokushige, Katsutoshi
    Koike, Kazuhiko
    Shima, Toshihide
    Kanbara, Yoshihiro
    Saibara, Toshiji
    Uto, Hirofumi
    Takami, Shiro
    Kawanaka, Miwa
    Komorizono, Yasuji
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2012, 42 (08) : 767 - 773
  • [13] Machine learning to predict progression of non-alcoholic fatty liver to non-alcoholic steatohepatitis or fibrosis
    Ghandian, Sina
    Thapa, Rahul
    Garikipati, Anurag
    Barnes, Gina
    Green-Saxena, Abigail
    Calvert, Jacob
    Mao, Qingqing
    Das, Ritankar
    JGH OPEN, 2022, 6 (03): : 196 - 204
  • [14] Molecular mechanisms of fibrosis progression in non-alcoholic steatohepatitis (NASH)
    Hellerbrand, C.
    LIVER CIRRHOSIS: FROM PATHOPHYSIOLOGY TO DISEASE MANAGEMENT, 2008, 162 : 75 - +
  • [15] TAUROURSODEOXYCHOLIC ACID ATTENUATES HEPATIC FIBROSIS IN A MOUSE MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
    Cho, E. J.
    Yu, S. J.
    Lee, J. -H.
    Yoon, J. -H.
    Lee, H. -S.
    JOURNAL OF HEPATOLOGY, 2012, 56 : S485 - S485
  • [16] Diabetes is a progression factor for hepatic fibrosis in a high fat fed mouse obesity model of non-alcoholic steatohepatitis
    Lo, Lisa
    McLennan, Susan V.
    Williams, Paul F.
    Bonner, James
    Chowdhury, Sumaiya
    McCaughan, Geoffrey W.
    Gorrell, Mark D.
    Yue, Dennis K.
    Twigg, Stephen M.
    JOURNAL OF HEPATOLOGY, 2011, 55 (02) : 435 - 444
  • [17] Hypothalamic orexin prevents non-alcoholic steatohepatitis and hepatocellular carcinoma in obesity
    Tsuneki, Hiroshi
    Maeda, Takahiro
    Takata, Shinjiro
    Sugiyama, Masanori
    Otsuka, Koyuki
    Ishizuka, Hinako
    Onogi, Yasuhiro
    Tokai, Emi
    Koshida, Chiaki
    Kon, Kanta
    Takasaki, Ichiro
    Hamashima, Takeru
    Sasahara, Masakiyo
    Rudich, Assaf
    Koya, Daisuke
    Sakurai, Takeshi
    Yanagisawa, Masashi
    Yamanaka, Akihiro
    Wada, Tsutomu
    Sasaoka, Toshiyasu
    CELL REPORTS, 2022, 41 (03):
  • [18] CHYMASE INHIBITOR PREVENTS THE DEVELOPMENT AND PROGRESSION OF NON-ALCOHOLIC STEATOHEPATITIS IN RATS
    Miyaoka, Yuta
    Jin, Denan
    Tashiro, Keitaro
    Komeda, Koji
    Masubuchi, Shinsuke
    Hirokawa, Fumitoshi
    Hayashi, Michihiro
    Takai, Shinji
    Uchiyama, Kazuhisa
    GASTROENTEROLOGY, 2017, 152 (05) : S1117 - S1117
  • [19] Obeticholic acid, a synthetic FXR agonist, prevents hepatic inflammation and fibrosis in a novel mouse model of non-alcoholic steatohepatitis
    Goto, Toshihiro
    Itoh, Michiko
    Kanai, Sayaka
    Suganami, Takayoshi
    Ogawa, Yoshihiro
    HEPATOLOGY, 2016, 64 : 797A - 798A
  • [20] Association of non-alcoholic steatohepatitis without significant fibrosis with hepatocellular carcinoma
    Bullock, RE
    Zaitoun, AM
    Aithal, GP
    Ryder, SD
    Beckingham, IJ
    Lobo, DN
    JOURNAL OF HEPATOLOGY, 2004, 41 (04) : 685 - 686
12345